InflaRx NVIFRX
Price$1.71

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 31 Dec 2025
Market Price $1.71Price as of 1 Oct 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 17.3%/yr (balance of the path).14.7% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 616.8%Yr 716.3%Yr 815.8%Yr 915.3%Yr 1014.7%
17.3% → 14.7%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1113.6%Yr 1212.4%Yr 1311.2%Yr 1410.0%Yr 158.9%Yr 167.7%Yr 176.5%Yr 185.3%Yr 194.2%Yr 203.0%
14.7% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 14.0%
Volatility vs market (adjusted beta)2.00

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetInflaRx NVIFRXHealth Care
Valuation
P/E—
P/S10,500.8×
P/B3.4×
EV / Revenue9,954.6×
EV / EBITDA-4.4×
Profitability
Gross margin—
Operating margin-153,255.3%
Net margin-155,582.1%
FCF margin-120,515.2%
Returns
ROE-109.7%
ROA-82.6%
ROIC—
Growth
Revenue growth (YoY)-79.9%
5-yr fwd EPS growth14.7%
Financial strength
Debt / Equity0.00×
Current ratio7.37×
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.